Latest news
Latest news
◆ EU regs plan sparks debate over treatment of secured borrowing ◆ Blistering corporate and FIG issuance but why are premiums rising in one market but not the other? ◆ UK Renters' Rights Act to impact UK buy-to-let RMBS market
New law expected to accelerate the dominance of professional landlords
Together added to the sterling market with a small ticket CRE CMBS
More articles
More articles
-
The Financial Industry Regulatory Authority has fined Barclays Capital $3 million for misrepresenting delinquency data in connection with the issuance of residential subprime mortgage-backed securitizations and for inadequate supervision of its staff.
-
Government entity Fannie Mae has again made revisions to its guidelines for mortgage services, removing language known as the “ability to pay” clause and making the Home Affordable Refinance Program more accessible to servicers, analysts say.
-
The U.K. Financial Services Authority’s call for increasingly stringent standards to combat a return of risky mortgage lending should not have much of an impact on prime U.K. residential mortgage-backed securities, according to Moody’s Investors Service.
-
Redwood Trust is expanding its network of correspondent lenders to originate loans for new commercial mortgage-backed securities transactions.
-
Placed issuance in European securitization is expected to increase in 2012, Citigroup analysts said Tuesday.
-
Market professionals hailed the resilience of Europe’s securitization market in 2011 in the face of sustained market turbulence and tighter regulatory restrictions.
-
The Federal Housing Finance Agency has teamed up with the Office of the Attorney General of New York to investigate banks’ practices as they relate to mortgage-backed securitizations.
-
A handful of U.K. residential mortgage-backed deals put on hold in 2011 are expected to be shipped back into market in the new year.
-
Investors are pressing bond trustees for an investigation of loans in residential mortgage-backed securities sold by units of JPMorgan Chase, according to the law firm Gibbs & Bruns, which is representing the investors.